AbbVie announced that Robert Michael has assumed the role of chief executive officer, CEO and has joined AbbVie’s Board of Directors, effective today. As previously announced, Michael succeeds Richard Gonzalez, who has served as CEO since the company’s inception in 2013. Gonzalez has become executive chairman of the board of directors. Michael previously served as president and chief operating officer of AbbVie and has been a longstanding member of AbbVie’s Executive Leadership Team.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie gets CHMP opinion recommending marketing authorization of epcoritamab
- AbbVie Acquires Celsius Therapeutics
- AbbVie acquires Celsius Therapeutics for $250M in cash
- FDA grants second approval for EPKINLY in r/r follicular lymphoma
- FDA grands second approval for AbbVie’s EPKINLY in follicular lymphoma Genmab